Trials / Completed
CompletedNCT02938650
Nitrosomonas Eutropha on Nitrolipids in the Skin
Assessing the Role of Nitrosomonas Eutropha on Nitrolipids in the Skin
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- University of California, Davis · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
We are looking to see how the addition of nitrosomonas alters the presence of nitrolipids and inflammatory cytokines on the skin.
Detailed description
We are looking to see how the nitrosomonas alters nitrolipids in the skin and the inflammatory cytokines of the skin. We will be using healthy subjects over the course of 2 weeks. Subjects will be using a neutral cleanser for one week prior to the study, skin microbiome,facial photography, lipid and cytokine measurements will be taken at baseline. Subjects will then start using nitrosomonas spray twice daily for one week. There is a portion of the study where the subjects will have skin microbiome, facial photography, lipid measurements, blood pressure measurements and a bloow draw before and after using the nitrosomonas spray for one week.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nitrosomonas eutropha | Subjects will get nitrosomonas eutropha to apply for one week. There is only one arm to this study. Subjects will apply the medication twice a day for one week. |
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2017-05-01
- Completion
- 2017-05-01
- First posted
- 2016-10-19
- Last updated
- 2017-10-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02938650. Inclusion in this directory is not an endorsement.